home / stock / dmt:cc / dmt:cc news

DMT:CC News and Press, Small Pharma Inc. From 10/31/22

Stock Information
Company Name: Small Pharma Inc.
Stock Symbol: DMT:CC
Market: TSXVC
Website: smallpharma.com
Menu
DMT:CC DMT:CC Quote DMT:CC Short DMT:CC News DMT:CC Articles DMT:CC Message Board
Get DMT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DMT:CC - Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028

SPL028 is the Company’s injectable deuterated DMT candidate with multi-layered IP protection The Phase I study aims to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of IM and IV administration of SPL028 LONDON, Oct. 31, 2022 (GLO...
DMT:CC - Second United States Patent Granted for Small Pharma's Psychedelics Portfolio

Brings total to twelve granted patents across the Company’s full portfolio LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused o...

DMT:CC - Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion of 12-week follow up anticipated by year end with data shortly thereafter SSRI drug interaction study init...

DMT:CC - Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder

LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces tha...
DMT:CC - Small Pharma Enters Into Automatic Share Purchase Plan

LONDON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announced tha...

DMT:CC - Small Pharma to Participate in Upcoming September Investor Conferences

LONDON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Geor...

DMT:CC - Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that...
DMT:CC - Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

LONDON, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that...

DMT:CC - Canadian Patent Grant Strengthens Small Pharma's International Position

LONDON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that...

DMT:CC - U.S. Patent Grant to Strengthen Small Pharma's DMT Patent Strategy With Injectable Formulation

Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company...
Previous 10 Next 10